Renal Toxicology/Nephrotoxicity of Cisplatin and Other Chemotherapeutic Agents
Authors:
- T.V. DupreTDT.V. Dupre
- C.N. SharpCSC.N. Sharp
- L.J. SiskindLSL.J. Siskind
- 1 January 2018
- book chapter
- Published by Elsevier
- p. 452-486
Abstract
No abstract availableThis publication has 243 references indexed in Scilit:
- Acute kidney injuryThe Lancet, 2012
- Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathyThe Journal of Nutritional Biochemistry, 2012
- The BCL-2 Family ReunionMolecular Cell, 2010
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced NephrotoxicityClinical Pharmacology & Therapeutics, 2009
- Role of glutathione S-transferase Pi in cisplatin-induced nephrotoxicityBiomedicine & Pharmacotherapy, 2009
- Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology GroupPediatric Blood & Cancer, 2008
- How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?Trends in Cell Biology, 2008
- Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicityBiochemical Pharmacology, 2007
- Cell DeathCell, 2004
- Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panelBiochemical Pharmacology, 1996